Philippines bill seeks disclosure of pharma firms' marketing costs
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies operating in the Philippines will be required to submit annual reports on their marketing expenditure or face the threat of penalties, should a new bill submitted to the country's House of Representatives become law.